Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2007
11/08/2007WO2007124755A1 Method for immunizing an avian species
11/08/2007WO2007124610A1 Antibodies binding to the extracellular domain of the receptor tyrosine kinase alk
11/08/2007WO2007109118A3 RECOMBINANT HUMAN CC 10 (rhCC10) FOR TREATMENT OF RESPIRATORY DISORDERS
11/08/2007WO2007107797A3 Fusion protein comprising an fc receptor binding polypeptide and an antigenic polypeptide for mediating an immune response
11/08/2007WO2007084321A3 Antibodies to ox-2/cd200 and uses thereof
11/08/2007WO2007076465A3 Cln248 antibody compositions and methods of use
11/08/2007WO2007072214A3 Methods of clustering gene and protein sequences
11/08/2007WO2007038868A3 Novel enediyne compound and uses thereof
11/08/2007WO2007025388A3 Anti-apoptotic protein antibodies
11/08/2007WO2006110883A8 Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
11/08/2007WO2002046458A9 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof
11/08/2007US20070260045 vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides
11/08/2007US20070259807 Growth Factor HTTER36
11/08/2007US20070259806 Brain-Associated Inhibitor of Tissue-Type Plasminogen Activator
11/08/2007US20070259422 isolated nucleic acid encoding an immunogenic peptide recognized by T lymphocytes; host cell transfected with the recombinant expression vector encoding an immunogenic protein; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/08/2007US20070259400 Antibodies
11/08/2007US20070259398 Microwave Assisted Deglycosylation of Proteins for Molecular Weight Determination by Mass Spectrometry
11/08/2007US20070259387 Monoclonal antibodies specific for anthrax spores and peptides derived from the antibodies thereof
11/08/2007US20070259386 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
11/08/2007US20070259383 Novel Genes involved in Epidermal differentiation, and uses thereof
11/08/2007US20070259372 Melanoma differentiation associated gene - 5 and promoter and uses thereof
11/08/2007US20070259358 which promote strand transfer activity of viral integrase, such as HIV integrase; screening molecules for antiviral activity comprising exposing the molecules to epithelial growth factors, fragments or nucleotides codes and determining the ability to modulate the interaction with retroviral integrases
11/08/2007US20070259342 Lymphoma associated molecules and uses therefor
11/08/2007US20070258999 Sars Virus Nucleotide and Amino Acid Sequences and Uses Thereof
11/08/2007US20070258991 Immunogenic agent therapy using plasmapheresis
11/08/2007US20070258985 Human mini-antibody cytotoxic for tumor cells which express the ERB-B2 receptor
11/08/2007US20070258984 Anti-neoplastic composition of 5-FU, leucovorin, irinotecan, oxaliplatin, capecitabine, paclitaxel or doxetaxel; breast cancer, colorectal cancer, rectal cancer, non-small cell lung cancer, non-Hodgkins lymphoma (NHL), renal cell cancer, prostate cancer, liver cancer
11/08/2007US20070258981 Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
11/08/2007US20070258980 Vascular endothelial cell growth factor antagonists and uses thereof
11/08/2007US20070258979 Interlukin receptor specific immunoglobulin for use in treatment and prevention of severe asthma, atopic dermatitis, fibrotic and chronic obstructive pulmonary diseases
11/08/2007US20070258978 Immunogenic Recombinant Antibody
11/08/2007US20070258977 Inhibiting OX-2 (also called CD200) gene expression to treat a tumor that is associated with increased CD200 expression; leukemia; phage display screening for antigens; monoclonal antibodies; fusion proteins; use of OX-2 preventing graft rejection, autoimmune disease, and in inducing tumor cell growth
11/08/2007US20070258975 Crystallization of Antibody or Fragment Thereof
11/08/2007US20070258968 modified deoxycytidine kinase (dCK) mutants with enhanced activity towards nucleoside analogs used in cancer chemotherapy, and delivering the enzymes to specific target cells; specifically delivered to leukemic blast cells
11/08/2007US20070258955 Lactobacillus acidophillus nucleic acid sequences encoding cell surface protein homologues and uses therefore
11/08/2007US20070258954 Directed evolution of enzymes and antibodies
11/08/2007US20070258949 Human Cdna Clones Comprising Polynucleotides Encoding Polypeptides and Methods of Their Use
11/08/2007US20070258944 Multiple cytokine protein complexes
11/08/2007US20070258897 Antibodies Against Bacterial Antigens and Their Use in the Generation of Immune Responses Against Apoptotic Cells
11/08/2007US20070258895 Estrogen Receptors and Methods of Use
11/08/2007DE10054303B4 Analoga, Agonisten, Antagonisten und Varianten der Oxidoreduktase-Enzymaktivität des Makrophagen-Migrations-Inhibitions-Faktors (MIF) als Immunmodulatoren, Therapeutika, Diagnostika und Screening-Agenzien bei inflammatorischen und Immunerkrankungen Analogues, agonists, antagonists, and variants of the oxidoreductase enzyme activity of macrophage migration inhibitory factor (MIF) as immunomodulators, therapeutic agents, diagnostic and screening agents in inflammatory and immune diseases
11/08/2007CA2650822A1 Antibodies binding to the extracellular domain of the receptor tyrosine kinase alk
11/08/2007CA2650730A1 Methods and compositions for antibody therapy
11/08/2007CA2650380A1 Monoclonal antibodies and their use
11/08/2007CA2648882A1 Humanized c-kit antibody
11/08/2007CA2647359A1 Tumor cell differentiation agents as chemical inhibitors and treatments for intracellular parasites
11/08/2007CA2646406A1 Anti-igf-ir antibodies and uses thereof
11/08/2007CA2646048A1 Compositions and methods of use for antibodies of c-met
11/08/2007CA2638133A1 Anti-ephrinb2 antibodies and methods using same
11/08/2007CA2631961A1 Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r
11/07/2007EP1852508A2 Actinomycetes polynucleotides
11/07/2007EP1852507A1 CRSP protein (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor
11/07/2007EP1852505A1 Mutations in ion channels
11/07/2007EP1852442A1 Antibody for assay of adamts13 activity and method of activity assay
11/07/2007EP1852128A1 An anti HSP90 antibody
11/07/2007EP1852127A1 Use of a B-cell-depleting antibody for treatment of polyoma virus infections
11/07/2007EP1852123A2 Activation and inhibition of the immune system
11/07/2007EP1851315A1 Human antibodies against rabies and uses thereof
11/07/2007EP1851251A2 Monoclonal antibodies against prostate specific membrane antigen (psma) lacking in fucosyl residues
11/07/2007EP1851250A2 Human monoclonal antibodies to prostate specific membrane antigen (psma)
11/07/2007EP1851249A2 Cd20 antibody variants and uses thereof
11/07/2007EP1851248A2 Anti-interferon alpha monoclonal antibodies and methods for use
11/07/2007EP1851247A2 Methods and compositions for impairing multiplication of hiv-1
11/07/2007EP1851246A1 Site-specific immunization in order to establish antibodies with specificity for the e7 oncoprotein of high-risk hpvs
11/07/2007EP1851245A2 Antibodies against interleukin-1 beta
11/07/2007EP1851244A1 An anti-cd137 antibody as an agent in the treatement of cancer and glycosylation variants thereof
11/07/2007EP1851238A2 Influenza nucleic acids, polypeptides, and uses thereof
11/07/2007EP1850873A2 Antibodies to tgfbeta
11/07/2007EP1850872A2 A method of using an anti-cd137 antibody as an agent for radioimmunotherapy or radioimmunodetection
11/07/2007EP1850866A2 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
11/07/2007EP1651684B1 Etherified carbamate functional copolymers of isobutylene type monomers, and their use in curable compositions
11/07/2007EP1565553A4 Recombinant catalytic polypeptides and their uses
11/07/2007EP1374901B9 Graft rejection suppressors
11/07/2007EP1144671B1 Enriched central nervous system cell populations
11/07/2007EP1003379B1 Novel phytase
11/07/2007CN101068936A Methods and systems for prognosis and treatment of solid tumors
11/07/2007CN101068836A Anti-glypican 3 antibody having modified sugar chain
11/07/2007CN101066999A Recombinant anti-OPN monoclonal antibody and its prepn and use
11/07/2007CN101066998A Prepn of specific antibody of provera acetate and method of using the antibody in homogenous or heterogenous enzyme-linked immune analysis
11/07/2007CN101066997A Human antibodies that bind human IL-12 and methods for producing
11/07/2007CN101066450A Antibody-containing solution preparation
11/07/2007CN101066447A Group b streptococcus proteins, and their use
11/07/2007CN100347296C Method for manufacturing antigen-specific antibody-producing hybridomas employing a single antigen-specific b lymphocyte and method for manufacturing monoclonal antibody
11/07/2007CN100347195C Preparation method of vitelline antibody for resisting pstudorabies
11/07/2007CN100347191C 新mhcⅱ相关肽 New mhcⅱ related peptide
11/07/2007CN100346827C Viral chimeras comprised of CAEV and HIV-1 genetic elements
11/06/2007US7291722 Polypeptide from haemophilus influenza
11/06/2007US7291721 Anti-IL-6 antibodies, compositions, methods and uses
11/06/2007US7291719 PRO4332 antibodies
11/06/2007US7291718 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders
11/06/2007US7291717 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
11/06/2007US7291716 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
11/06/2007US7291715 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
11/06/2007US7291714 A non-human antibody or fragment that specifically binds to a platelet membrane glycoprotein that is involved platelet-collagen interactions
11/06/2007US7291710 Detection of spectrin and spectrin proteolytic cleavage products in assessing nerve cell damage
11/06/2007US7291709 LSR (Lipolysis Stimulated Receptor); for the prevention and/or treatment of pathologies and/or of pathogeneses such as obesity and anorexia, hyperlipidemias, atherosclerosis, diabetes, hypertension
11/06/2007US7291702 For release of tumor necrosis factor and/or cellular proliferation/differentiation of chrondrocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
11/06/2007US7291700 PRO4985 polypeptide
11/06/2007US7291495 β-Secretase variant
11/06/2007US7291492 Histone deactylase for use in identifying modulators for prevention and treatment of cell proliferative disorders
1 ... 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 ... 1494